These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

637 related items for PubMed ID: 28421406

  • 1. Whole body MRI with qualitative and quantitative analysis of DWI for assessment of bone marrow involvement in lymphoma.
    Balbo-Mussetto A, Saviolo C, Fornari A, Gottardi D, Petracchini M, Macera A, Lario CV, Gallo T, Tarella C, Cirillo S.
    Radiol Med; 2017 Aug; 122(8):623-632. PubMed ID: 28421406
    [Abstract] [Full Text] [Related]

  • 2. Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma.
    Albano D, Patti C, Lagalla R, Midiri M, Galia M.
    J Magn Reson Imaging; 2017 Apr; 45(4):1082-1089. PubMed ID: 27603267
    [Abstract] [Full Text] [Related]

  • 3. Whole-body MRI with diffusion-weighted imaging: a valuable alternative to contrast-enhanced CT for initial staging of aggressive lymphoma.
    Balbo-Mussetto A, Cirillo S, Bruna R, Gueli A, Saviolo C, Petracchini M, Fornari A, Lario CV, Gottardi D, De Crescenzo A, Tarella C.
    Clin Radiol; 2016 Mar; 71(3):271-9. PubMed ID: 26749081
    [Abstract] [Full Text] [Related]

  • 4. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
    Berthet L, Cochet A, Kanoun S, Berriolo-Riedinger A, Humbert O, Toubeau M, Dygai-Cochet I, Legouge C, Casasnovas O, Brunotte F.
    J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577
    [Abstract] [Full Text] [Related]

  • 5. 18F-FDG PET-CT imaging versus bone marrow biopsy in pediatric Hodgkin's lymphoma: a quantitative assessment of marrow uptake and novel insights into clinical implications of marrow involvement.
    Hassan A, Siddique M, Bashir H, Riaz S, Wali R, Mahreen A, Nawaz MK.
    Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1198-1206. PubMed ID: 28229191
    [Abstract] [Full Text] [Related]

  • 6. Bone Marrow Involvement in Malignant Lymphoma: Evaluation of Quantitative PET and MRI Biomarkers.
    Asenbaum U, Nolz R, Karanikas G, Furtner J, Woitek R, Simonitsch-Klupp I, Raderer M, Mayerhoefer ME.
    Acad Radiol; 2018 Apr; 25(4):453-460. PubMed ID: 29199055
    [Abstract] [Full Text] [Related]

  • 7. Is it sufficient to evaluate bone marrow involvement in newly diagnosed lymphomas using 18F-FDG PET/CT and/or routine iliac crest biopsy? A new approach of PET/CT-guided targeted bone marrow biopsy.
    Hao B, Zhao L, Luo NN, Ruan D, Pang YZ, Guo W, Fu H, Guo XY, Luo ZM, Wu J, Chen HJ, Wu H, Sun L.
    BMC Cancer; 2018 Nov 29; 18(1):1192. PubMed ID: 30497426
    [Abstract] [Full Text] [Related]

  • 8. Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy.
    Teagle AR, Barton H, Charles-Edwards E, Dizdarevic S, Chevassut T.
    Acta Radiol; 2017 Dec 29; 58(12):1476-1484. PubMed ID: 28382828
    [Abstract] [Full Text] [Related]

  • 9. Can Positron Emission Tomography and Computed Tomography Be a Substitute for Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Patients with Hodgkin's or Non-Hodgkin's Lymphoma?
    Çetin G, Çıkrıkçıoğlu MA, Özkan T, Karatoprak C, Ar MC, Eşkazan AE, Ayer M, Cerit A, Gözübenli K, Uysal BB, Erdem S, Ergül N, Tatar G, Çermik TF.
    Turk J Haematol; 2015 Sep 29; 32(3):213-9. PubMed ID: 25912844
    [Abstract] [Full Text] [Related]

  • 10. Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise?
    Adams HJ, Kwee TC, Fijnheer R, Dubois SV, Nievelstein RA, de Klerk JM.
    Acta Radiol; 2015 Oct 29; 56(10):1230-5. PubMed ID: 25387723
    [Abstract] [Full Text] [Related]

  • 11. Whole-body MRI versus an [18F]FDG-PET/CT-based reference standard for early response assessment and restaging of paediatric Hodgkin's lymphoma: a prospective multicentre study.
    Spijkers S, Littooij AS, Kwee TC, Tolboom N, Beishuizen A, Bruin MCA, Enríquez G, Sábado C, Miller E, Granata C, de Lange C, Verzegnassi F, de Keizer B, Nievelstein RAJ.
    Eur Radiol; 2021 Dec 29; 31(12):8925-8936. PubMed ID: 34021390
    [Abstract] [Full Text] [Related]

  • 12. (18)F-FDG PET/CT bone/bone marrow findings in Hodgkin's lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging.
    Moulin-Romsee G, Hindié E, Cuenca X, Brice P, Decaudin D, Bénamor M, Brière J, Anitei M, Filmont JE, Sibon D, de Kerviler E, Moretti JL.
    Eur J Nucl Med Mol Imaging; 2010 Jun 29; 37(6):1095-105. PubMed ID: 20204358
    [Abstract] [Full Text] [Related]

  • 13. Whole-body MRI versus an FDG-PET/CT-based reference standard for staging of paediatric Hodgkin lymphoma: a prospective multicentre study.
    Spijkers S, Littooij AS, Kwee TC, Tolboom N, Beishuizen A, Bruin MCA, Elias SG, van de Brug T, Enríquez G, Sábado C, Miller E, Granata C, de Lange C, Verzegnassi F, Greer MC, de Keizer B, Nievelstein RAJ.
    Eur Radiol; 2021 Mar 29; 31(3):1494-1504. PubMed ID: 32880696
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of [18F]-FDG-Based Hybrid Imaging Combinations for Assessment of Bone Marrow Involvement in Lymphoma at Initial Staging.
    Asenbaum U, Nolz R, Karanikas G, Furtner J, Woitek R, Staudenherz A, Senn D, Raderer M, Weber M, Simonitsch-Klupp I, Mayerhoefer ME.
    PLoS One; 2016 Mar 29; 11(10):e0164118. PubMed ID: 27723817
    [Abstract] [Full Text] [Related]

  • 15. Bone marrow evaluation in initial staging of lymphoma: 18F-FDG PET/CT versus bone marrow biopsy.
    Cortés-Romera M, Sabaté-Llobera A, Mercadal-Vilchez S, Climent-Esteller F, Serrano-Maestro A, Gámez-Cenzano C, González-Barca E.
    Clin Nucl Med; 2014 Jan 29; 39(1):e46-52. PubMed ID: 23640215
    [Abstract] [Full Text] [Related]

  • 16. Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients.
    Abdulqadhr G, Molin D, Aström G, Suurküla M, Johansson L, Hagberg H, Ahlström H.
    Acta Radiol; 2011 Mar 01; 52(2):173-80. PubMed ID: 21498346
    [Abstract] [Full Text] [Related]

  • 17. Bone marrow FDG-PET/CT in Hodgkin lymphoma revisited: do imaging and pathology match?
    Adams HJ, Kwee TC, Fijnheer R, Dubois SV, Nievelstein RA, de Klerk JM.
    Ann Nucl Med; 2015 Feb 01; 29(2):132-7. PubMed ID: 25348549
    [Abstract] [Full Text] [Related]

  • 18. Whole-body diffusion-weighted MRI and (18)F-FDG PET/CT can discriminate between different lymphoma subtypes.
    Mosavi F, Wassberg C, Selling J, Molin D, Ahlström H.
    Clin Radiol; 2015 Nov 01; 70(11):1229-36. PubMed ID: 26208992
    [Abstract] [Full Text] [Related]

  • 19. Whole body magnetic resonance with diffusion weighted sequence with body signal suppression compared to (18)F-FDG PET/CT in newly diagnosed lymphoma.
    Ferrari C, Minoia C, Asabella AN, Nicoletti A, Altini C, Antonica F, Ficco M, Guarini A, Maggialetti N, Rubini G.
    Hell J Nucl Med; 2014 Nov 01; 17 Suppl 1():40-9. PubMed ID: 24392468
    [Abstract] [Full Text] [Related]

  • 20. Can FDG-PET/CT replace blind bone marrow biopsy of the posterior iliac crest in Ewing sarcoma?
    Kasalak Ö, Glaudemans AWJM, Overbosch J, Jutte PC, Kwee TC.
    Skeletal Radiol; 2018 Mar 01; 47(3):363-367. PubMed ID: 29124298
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.